Elan CEO Kelly Martin

Elan CEO Kelly Martin

Barry Cronin/Bloomberg

Kelly Martin, Elan’s CEO since 2003, has responded to Royalty Pharma's bid with four proposed transactions he bills as a value-creating alternative to the takeover plan.